POSTHERPETIC NEURALGIA
Clinical trials for POSTHERPETIC NEURALGIA explained in plain language.
Never miss a new study
Get alerted when new POSTHERPETIC NEURALGIA trials appear
Sign up with your email to follow new studies for POSTHERPETIC NEURALGIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shingles nerve block shows promise in preventing chronic pain
Disease control CompletedThis study tested whether an ultrasound-guided nerve block, using a steroid and local anesthetic, could better control pain from shingles and prevent postherpetic neuralgia (long-term nerve pain). 100 adults with acute shingles and moderate to severe pain were randomly assigned t…
Matched conditions: POSTHERPETIC NEURALGIA
Phase: PHASE3 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug shows promise for shingles nerve pain
Symptom relief CompletedThis study tested an experimental drug called LX9211 in 79 adults with postherpetic neuralgia, a type of nerve pain that can last for months after a shingles rash heals. The goal was to see if the drug reduces pain and helps with sleep compared to a placebo over 11 weeks. Partici…
Matched conditions: POSTHERPETIC NEURALGIA
Phase: PHASE2 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Acupuncture with a jolt: new hope for shingles nerve pain?
Symptom relief CompletedThis completed trial tested whether electroacupuncture (acupuncture with a mild electric current) can reduce pain in people with postherpetic neuralgia, a lingering nerve pain after shingles. 448 adults aged 45-75 with moderate-to-severe pain were randomly assigned to real or sha…
Matched conditions: POSTHERPETIC NEURALGIA
Phase: NA • Sponsor: Nanjing University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New drug KAI-1678 tested for shingles nerve pain relief
Symptom relief CompletedThis Phase 2 trial tested whether a single dose of KAI-1678 can reduce pain in people with postherpetic neuralgia, a type of nerve pain that lingers after shingles. 23 adults with stable pain levels received either KAI-1678, a placebo, or lidocaine. The main goal was to see if pa…
Matched conditions: POSTHERPETIC NEURALGIA
Phase: PHASE2 • Sponsor: KAI Pharmaceuticals • Aim: Symptom relief
Last updated Jun 26, 2026 13:06 UTC
-
Can nerve zapping predict who gets pain relief from shingles?
Knowledge-focused CompletedThis study looked at 77 adults with long-term nerve pain after shingles (postherpetic neuralgia) to see if a spinal nerve stimulation device works better for certain types of pain. Researchers grouped patients by their pain features and measured pain levels, quality of life, and …
Matched conditions: POSTHERPETIC NEURALGIA
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC